KLK6 and myeloid sarcoma: Given the relatively widespread distribution of KLK6 in human tissues [3], [58], [59], and increasing awareness of its regulation in disease [1], [4], [28], [58], [60], [61], [62], [63], this novel enzyme is in a position to play an important regulatory role in immune-related disorders, including but not limited to MS.